Needham Initiates Camp4 Therapeutics Coverage With Buy Rating, $8 Target
Needham initiated coverage of Camp4 Therapeutics with a Buy rating and an $8.00 price target. The target implies 133.2% upside from the Oct. 14 close of $3.43.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.